Cyclerion Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CYCN and other ETFs, options, and stocks.

About CYCN

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for serious and orphan diseases, through the use of soluble guanylate cyclase (sGC) pharmacology. Its product pipeline includes several sGC stimulators, a small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate (cGMP). 

CEO
Peter M. Hecht
CEOPeter M. Hecht
Employees
32
Employees32
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2018
Founded2018
Employees
32
Employees32

CYCN Key Statistics

Market cap
36.96M
Market cap36.96M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
84.38K
Average volume84.38K
High today
$0.8899
High today$0.8899
Low today
$0.8001
Low today$0.8001
Open price
$0.8663
Open price$0.8663
Volume
74.42K
Volume74.42K
52 Week high
$3.37
52 Week high$3.37
52 Week low
$0.4613
52 Week low$0.4613

CYCN Earnings

-$0.55
-$0.37
-$0.18
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 8, Pre-Market
ActualExpected Nov 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.